NEW YORK — Fluidigm said on Thursday that it has launched a program to provide millions of its saliva-based SARS-CoV-2 tests to US colleges and universities at low cost.
NEW YORK — Fluidigm said on Thursday that it has launched a program to provide millions of its saliva-based SARS-CoV-2 tests to US colleges and universities at low cost.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.